Masayasu Iwabuchi, MD,PhD

Seirei Mikatahara General Hospital
Hamamatsu, JAPAN

Disclosure information not submitted.

Presentation(s):

• MON-322 - Administration of Inclisiran Sodium Is A Tumor-Biologically Beneficial Treatment for Cancer-Associated Hyperlipidemia during Chemotherapy for Prostate Cancer

  Monday, June 15, 2026
  9:00 AM - 2:00 PM CT